Editors' ChoiceHIV Broadening vaccine strategies to induce HIV broadly neutralizing antibodies Michelle BoyleImmunology Department, QIMR-Berghofer, Herston, Queensland 4006, Australia. Email: michelle.boyle{at}qirmberghofer.edu.au See allHide authors and affiliations Science Translational Medicine 14 Aug 2019:Vol. 11, Issue 505, eaay7699DOI: 10.1126/scitranslmed.aay7699 Michelle Boyle Immunology Department, QIMR-Berghofer, Herston, Queensland 4006, Australia. Email: Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: michelle.boyle@qirmberghofer.edu.au Article Info & Metrics eLetters Article Information vol. 11 no. 505 DOI: https://doi.org/10.1126/scitranslmed.aay7699 Published By: American Association for the Advancement of Science Print ISSN: 1946-6234 Online ISSN: 1946-6242 History: . Copyright & Usage: Copyright © 2019, American Association for the Advancement of Science Author Information Michelle BoyleImmunology Department, QIMR-Berghofer, Herston, Queensland 4006, Australia. Email: michelle.boyle{at}qirmberghofer.edu.au Altmetric Article usage Article lifetimeLast 6 monthsThis monthArticle usage: August 2019 to April 2021 AbstractFullPdf Aug 201921424197 Sep 2019121460 Oct 20195990 Nov 201991520 Dec 2019101220 Jan 20204690 Feb 20206710 Mar 20205710 Apr 20201670 May 20202460 Jun 202011330 Jul 20202830 Aug 202041000 Sep 20202380 Oct 20203390 Nov 20204540 Dec 20203570 Jan 20211250 Feb 20211330 Mar 20211290 Apr 20211170 View Full Text
Broadening vaccine strategies to induce HIV broadly neutralizing antibodies By Michelle Boyle Science Translational Medicine14 Aug 2019 Vaccination with anti-idiotype antibodies can activate and target germline B cell precursors of HIV broadly neutralizing antibodies.
Broadening vaccine strategies to induce HIV broadly neutralizing antibodies By Michelle Boyle Science Translational Medicine14 Aug 2019 Vaccination with anti-idiotype antibodies can activate and target germline B cell precursors of HIV broadly neutralizing antibodies.